A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response (HAMMER) in non-small cell lung cancer Meeting Abstract
| Authors: | McMillan, M. T.; Gomez, D. R.; Reyngold, M.; Hajj, C.; O'Brien, D. A. R.; Crane, C. H.; Gönen, M.; Bott, M.; Schoenfeld, A. J.; Romesser, P. B. |
| Abstract Title: | A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response (HAMMER) in non-small cell lung cancer |
| Meeting Title: | 66th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2024) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 120 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2024 Sep 29-Oct 2 |
| Meeting Location: | Washington, DC |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | e471 |
| Language: | English |
| ACCESSION: | WOS:001325892301373 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2024.07.1048 |
| Notes: | Meeting Abstract: 3044 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
1028Gonen -
237Gomez -
103Reyngold -
135Bott -
164Hajj -
188Romesser -
32Roth O'Brien -
201Crane -
131Schoenfeld -
11Mcmillan